News

People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.

A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.

Initial results suggest the treatment has the potential to alter the course of the disease.

The research aims to improve patient care and safety in acute and critical care, surgical care and perioperative care settings.

An exciting new genetic therapy for Alzheimer’s disease is safe and successfully lowered levels of the harmful tau protein known to cause the disease, in a world first trial at UCLH and UCL.

UCLH is the first site in the UK to open in a world-first trial for people living with progressive forms of multiple sclerosis.

Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.

Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.

A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.

A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.